JMI Syringes & Medical Devices Ltd has recommended 30 percent cash dividend for the year ended on June 30, 2020. The approval of the dividend was given in the annual general meeting (AGM) of the organisation, held virtually on Tuesday at it’s corporate office Unique Heights, Kazi Nazrul Islam Avenue, in Dhaka.
According to the AGM, the company's earnings per share (EPS) for the year ended (FY 2019-20) was Tk4.35 which was Tk3.1 in the previous fiscal year.
The company's net asset value (NAV) per share of Tk121.66 for the year ended on June 30, 2020 as against Tk 68.74 for the same period of the previous year.
In the FY 2019-20, the total sales were Tk197.65 crore which was Tk20 crore more than the last financial year.
Jabed Iqbal Pathan, chairman of the company, said, they have been paying 30 percent cash dividend since last four years.
He said, adverse since it was listed on the stock exchange, JMI Syringes & Medical Devices has paid a total of Tk34.90 crore in dividends to shareholders.
Md. Abdur Razzaq, founding managing director of the company said, “despite various adversities in the past years, the quality of the company's products has been praised at the international level.
He said, “As the only company in Bangladesh, we are able to produce syringes (Auto Disable-AD) used for corona vaccination. As a result, we have already exported Tk1.5 crore syringes for corona vaccination activities in Indonesia and 26 lakh syringes are being exported to Pakistan.
“Besides, many other countries are communicating with us regarding on syringes export including the United States.” He added.
Abdur Razzaq also said that if the government takes the initiative to buy AD syringes for corona vaccination, the country will be ready to produce and supply the required syringes with priority.
